Krajden M - Search Results

1

Health care costs associated with hepatitis C: a longitudinal cohort study.

Krajden M, Kuo M, Zagorski B, Alvarez M, Yu A, Krahn M. Krajden M, et al. Can J Gastroenterol. 2010 Dec;24(12):717-26. doi: 10.1155/2010/569692. Can J Gastroenterol. 2010. PMID: 21165379 Free PMC article.

2

Parvovirus B19 in an immunocompetent adult patient with acute liver failure: an underdiagnosed cause of acute non-A-E viral hepatitis.

Ho JK, Tha SP, Coupland R, Dalal BI, Bowie WR, Sreenivasan GM, Krajden M, Yoshida EM. Ho JK, et al. Among authors: krajden m. Can J Gastroenterol. 2005 Mar;19(3):161-2. doi: 10.1155/2005/853947. Can J Gastroenterol. 2005. PMID: 15776137

3

Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.

Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Grebely J, et al. Among authors: krajden m. Can J Gastroenterol. 2007 Jul;21(7):447-51. doi: 10.1155/2007/796325. Can J Gastroenterol. 2007. PMID: 17637948 Free PMC article.

4

Capacity enhancement of hepatitis C virus treatment through integrated, community-based care.

Hill WD, Butt G, Alvarez M, Krajden M. Hill WD, et al. Among authors: krajden m. Can J Gastroenterol. 2008 Jan;22(1):27-32. doi: 10.1155/2008/369827. Can J Gastroenterol. 2008. PMID: 18209777 Free PMC article.

5

Publicly funded pegylated interferon-alpha treatment in British Columbia: disparities in treatment patterns for people with hepatitis C.

Hsu PC, Buxton JA, Tu AW, Hill WD, Yu A, Krajden M. Hsu PC, et al. Among authors: krajden m. Can J Gastroenterol. 2008 Apr;22(4):359-64. doi: 10.1155/2008/243607. Can J Gastroenterol. 2008. PMID: 18414709 Free PMC article.

6

Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal Canadians.

Cooper CL, Bailey RJ, Bain VG, Anderson F, Yoshida EM, Krajden M, Marotta P; Canadian Pegasys Study Group. Cooper CL, et al. Among authors: krajden m. Can J Gastroenterol. 2008 Aug;22(8):677-80. doi: 10.1155/2008/320150. Can J Gastroenterol. 2008. PMID: 18701944 Free PMC article.

7

Genotype D amongst injection drug users with acute hepatitis B virus infection in British Columbia.

Panessa C, Hill WD, Giles E, Yu A, Harvard S, Butt G, Andonov A, Krajden M, Osiowy C. Panessa C, et al. Among authors: krajden m. J Viral Hepat. 2009 Jan;16(1):64-73. doi: 10.1111/j.1365-2893.2008.01045.x. J Viral Hepat. 2009. PMID: 19192159

8

Does cirrhosis affect quality of life in hepatitis C virus-infected patients?

Hsu PC, Krajden M, Yoshida EM, Anderson FH, Tomlinson GA, Krahn MD. Hsu PC, et al. Among authors: krajden m. Liver Int. 2009 Mar;29(3):449-58. doi: 10.1111/j.1478-3231.2008.01865.x. Liver Int. 2009. PMID: 19267865

9

Re-treatment with peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have relapsed or not responded to a first course of pegylated interferon-based therapy.

Yoshida EM, Sherman M, Bain VG, Cooper CL, Deschênes M, Marotta PJ, Lee SS, Krajden M, Witt-Sullivan H, Bailey RJ, Usaty C, Peltekian K; Pegasys Study Group. Yoshida EM, et al. Among authors: krajden m. Can J Gastroenterol. 2009 Mar;23(3):180-4. doi: 10.1155/2009/470532. Can J Gastroenterol. 2009. PMID: 19319382 Free PMC article.

10

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

John-Baptiste AA, Tomlinson G, Hsu PC, Krajden M, Heathcote EJ, Laporte A, Yoshida EM, Anderson FH, Krahn MD. John-Baptiste AA, et al. Among authors: krajden m. Am J Gastroenterol. 2009 Oct;104(10):2439-48. doi: 10.1038/ajg.2009.346. Epub 2009 Jun 30. Am J Gastroenterol. 2009. PMID: 19568230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters